Pfizer Inc.
US ˙ NYSE ˙ US7170811035

SecurityPFE / Pfizer Inc.
InstitutionFoster & Motley Inc
Latest Disclosed Ownership160,338 shares
Latest Disclosed Value $ 4,502
Foster & Motley Inc reports 3.61% increase in ownership of PFE / Pfizer Inc.

On April 21, 2026 - Foster & Motley Inc filed a 13F-HR form disclosing ownership of 160,338 shares of Pfizer Inc. (US:PFE) valued at $4,502,291 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 154,753 shares of Pfizer Inc.. This represents a change in shares of 3.61% during the quarter. The current value of the position is $4,119,083 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F Pfizer com 717081103 160,338 5,585 3.61 5 33.33 0.2323
2026-01-15 2025-12-31 13F Pfizer com 717081103 154,753 14,670 10.47 4 0.00 0.2055
2025-10-23 2025-09-30 13F Pfizer com 717081103 140,083 -1,834 -1.29 4 0.00 0.1924
2025-07-29 2025-06-30 13F Pfizer com 717081103 141,917 21,246 17.61 3 0.00 0.1987
2025-05-08 2025-03-31 13F Pfizer com 717081103 120,671 -2,262 -1.84 3 0.00 0.1925
2025-01-23 2024-12-31 13F Pfizer com 717081103 122,933 -22,368 -15.39 3 -25.00 0.2121
2024-10-30 2024-09-30 13F Pfizer com 717081103 145,301 -12,747 -8.07 4 0.00 0.2667
2024-08-02 2024-06-30 13F Pfizer com 717081103 158,048 -9,431 -5.63 4 0.00 0.3039
2024-04-18 2024-03-31 13F Pfizer com 717081103 167,479 -20,075 -10.70 5 -20.00 0.3200
2024-02-01 2023-12-31 13F Pfizer com 717081103 187,554 -9,797 -4.96 5 -16.67 0.4012
2023-10-24 2023-09-30 13F Pfizer com 717081103 197,351 -11,683 -5.59 7 -14.29 0.5367
2023-08-08 2023-06-30 13F Pfizer com 717081103 209,034 -14,796 -6.61 8 -22.22 0.5939
2023-05-09 2023-03-31 13F Pfizer com 717081103 223,830 -7,831 -3.38 9 -18.18 0.7431
2023-02-09 2022-12-31 13F Pfizer com 717081103 231,661 -3,424 -1.46 12 -99.89 1.0132
2022-11-04 2022-09-30 13F Pfizer com 717081103 235,085 1,570 0.67 10,287 -15.98 0.9767
2022-08-09 2022-06-30 13F Pfizer com 717081103 233,515 -2,179 -0.92 12,243 0.34 1.0759
2022-04-28 2022-03-31 13F Pfizer com 717081103 235,694 -3,633 -1.52 12,202 -13.66 0.9568
2022-01-25 2021-12-31 13F Pfizer com 717081103 239,327 -9,266 -3.73 14,132 32.17 1.0996
2021-10-29 2021-09-30 13F Pfizer com 717081103 248,593 -866 -0.35 10,692 9.45 0.8901
2021-07-20 2021-06-30 13F Pfizer com 717081103 249,459 1,558 0.63 9,769 8.77 0.8181
2021-04-26 2021-03-31 13F Pfizer com 717081103 247,901 -194 -0.08 8,981 -1.65 0.7489
2021-02-01 2020-12-31 13F Pfizer com 717081103 248,095 11,298 4.77 9,132 5.09 0.8822
2020-10-19 2020-09-30 13F Pfizer com 717081103 236,797 -8,609 -3.51 8,690 8.29 1.0238
2020-07-20 2020-06-30 13F Pfizer com 717081103 245,406 1,213 0.50 8,025 0.69 1.0039
2020-04-21 2020-03-31 13F Pfizer com 717081103 244,193 -9,723 -3.83 7,970 -19.88 1.1888
2020-02-05 2019-12-31 13F Pfizer com 717081103 253,916 -4,968 -1.92 9,948 6.94 1.2461
2019-10-24 2019-09-30 13F Pfizer com 717081103 258,884 -3,867 -1.47 9,302 -18.27 1.2674
2019-07-17 2019-06-30 13F Pfizer com 717081103 262,751 -1,546 -0.58 11,382 1.40 1.5957
2019-05-08 2019-03-31 13F Pfizer com 717081103 264,297 4,280 1.65 11,225 -1.10 1.6179
2019-01-30 2018-12-31 13F Pfizer com 717081103 260,017 -2,447 -0.93 11,350 -1.88 1.8168
2018-10-31 2018-09-30 13F Pfizer com 717081103 262,464 -5,757 -2.15 11,567 18.87 1.7351
2018-07-24 2018-06-30 13F Pfizer com 717081103 268,221 1,655 0.62 9,731 2.86 1.5517
2018-05-14 2018-03-31 13F Pfizer com 717081103 266,566 -10,394 -3.75 9,460 -5.69 1.5413
2018-01-22 2017-12-31 13F Pfizer com 717081103 276,960 -5,832 -2.06 10,031 -0.64 1.6030
2017-10-19 2017-09-30 13F Pfizer com 717081103 282,792 -12,212 -4.14 10,096 1.89 1.7375
2017-07-31 2017-06-30 13F Pfizer com 717081103 295,004 -3,759 -1.26 9,909 -3.05 1.7506
2017-04-24 2017-03-31 13F Pfizer com 717081103 298,763 9,501 3.28 10,221 8.79 1.8634
2017-01-19 2016-12-31 13F Pfizer com 717081103 289,262 17,101 6.28 9,395 1.92 1.7979
2016-10-28 2016-09-30 13F Pfizer com 717081103 272,161 32,083 13.36 9,218 9.05 1.7788
2016-08-02 2016-06-30 13F Pfizer com 717081103 240,078 8,108 3.50 8,453 22.93 1.6690
2016-04-20 2016-03-31 13F Pfizer com 717081103 231,970 39,607 20.59 6,876 10.74 1.3923
2016-01-25 2015-12-31 13F Pfizer com 717081103 192,363 4,958 2.65 6,209 5.49 1.3172
2015-11-09 2015-09-30 13F Pfizer com 717081103 187,405 -6,550 -3.38 5,886 -9.49 1.3393
2015-08-10 2015-06-30 13F Pfizer com 717081103 193,955 -22,587 -10.43 6,503 -13.67 1.4272
2015-04-16 2015-03-31 13F Pfizer com 717081103 216,542 -7,956 -3.54 7,533 7.72 1.6539
2015-01-22 2014-12-31 13F Pfizer com 717081103 224,498 -4,515 -1.97 6,993 3.26 1.5839
2014-10-16 2014-09-30 13F Pfizer com 717081103 229,013 8,983 4.08 6,772 3.71 1.5723
2014-07-25 2014-06-30 13F Pfizer com 717081103 220,030 8,012 3.78 6,530 -4.11 1.5074
2014-04-23 2014-03-31 13F Pfizer com 717081103 212,018 18,871 9.77 6,810 15.11 1.6740
2014-01-17 2013-12-31 13F Pfizer com 717081103 193,147 2,095 1.10 5,916 7.80 1.4927
2013-10-16 2013-09-30 13F Pfizer com 717081103 191,052 618 0.32 5,488 2.89 1.4647
2013-07-17 2013-06-30 13F Pfizer com 717081103 190,434 190,434 5,334 1.4828
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.